Inflexion has announced that it has agreed to acquire Pharmaspectra, a leading global provider of medical affairs data to the pharmaceutical and biotech industry. The investment is being made by Inflexion Enterprise Fund IV, Inflexion's dedicated lower mid‐market fund. Founded in...The post Inflexion has Announced Buyout of Pharmaspectra appeared first on Closing Circle.
Pharmaspectra is a New York-based health information platform that provides solutions such as scientific data, KOL mapping, and impact measurement for the pharmaceutical sector.